
--- Page 1 ---
(For Collection of Cancerous Tissue). Informed Consent I personally informed this patient that a specimen(s) would be collected to be used for research purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT FORM with the patient and answered any questions the patient had. The patient then signed the consent form as a free and voluntary act. A copy of this informed consent document will be retained at our institution. Name of Physician or Study Coordinator Signature Date Clinical Information Date of Birth (mm/dd/yyyy) Height Marital Status Race Temperature Gender Weight Blood Pressure Heart Rate ASHISTORY OFPRESENTILLNESS Symptoms: Weiqht loss j tined oy ealinc Clinical Findings: Performance Scale (Karnofsky Score):  100 Asymptomatic A80-90 Symptomatic but Fully Ambulatory   60-70 Symptomatic, in bed less than 50% of day  40-50 Symptomatic, in bed more than 50% of day, but not bed ridden   20-30 Bed Ridden Drug Dose Route Frequency Date (mm/dd/yyyy) To To To To To

--- Page 2 ---
SSPAST MEDICALHISTORYE Diagnosis/Disease/Disorder/Injury  Diagnosis Date Treatment Status Occupation: Environmental Hazards: Smoking History. Current Status. TYPE Packs/day Duration When Quit YES NO (yrs) (yr) Alcohol Consumption Current Status TYPE Drinks/day Duration When Quit  YES gNO (yrs) (yr) Drug Use Current Status TypE  Frequency Duration When Quit  YES NO (yrs) (yr FAMILYMEDICALHISTORYSSA Relative Diagnosis Age of Diagnosis. Result Test Result Date Test Dot. HIV  Positive: CEA  Negative  Positive: Negative Hep B Negative CA 15-3  Negative  Positive:  Positive:  Positive: CA 19-9 Hep C Negative  Negative  Positive: PSA  Negative  Positive: AFP  Negative  Positive: Other: Other:  Negative  Positive:  Negative  Positive: B/T Cell Markers:. 2

--- Page 3 ---
SSESSDIAGNOSTIC STUDIES  Study Results Date Ultrasound X-Ray CT Endoscopy A... A tumour in the Ascenoliugy Loler MRI  Biopsy CLINICAL DIAGNOSIS  Preoperative Clinical Diagnosis Location of Suspected Involved Lymph Nodes Location of Suspected Distant Metastasis Clinical Staging Date of Diaanosi T3 NO MO Stage: IA Treatment Information SURGICALTREATMENTE Procedure Date of Procedure H e xi saloetoons Primary Tumor Organ Detailed Location Size Clim lumer Y x 3 x Zcm Extension of Tumor Lymph Nodes Description Location of Lymph Nodes. # of Lymph Nodes Palpable, Non-Dissected Lymph Nodes Dissected Lymph Nodes Distant Metastasis Organ Detailed Location Size Surgical Staging Tz ND M O Stage: TA NEOADJUVENT THERAPY (Chemo, Radiation,Immuno,Hormonal, or Molecular) Dose Frequency Date (mm/dd/yyyy) Drug/Treatment Route To / To / / To / / / To / / To 3

--- Page 4 ---
Pathology Form Specimen Information Collected by: Date ime Preserved by: Dat ime: SPECIMEN TYPE# of samples provided Frozen Paraffin Block Blood/Serum/Plasma Slide Diseased  Normal Diseased Normal Diseased  Normal Diseased Normal 2 2 Time to LN2 'Time to Formalin Time to LN2 /2 min 3 min min Primary Tumor Organ Size Extension of Tumor Distance to NAT Colim tesner 6 4 x 3 x Z cmA<Cegg?iiG cm Lymph Nodes Location # Examined # Metastasized Distant Metastasis Organ Detailed Location Size Pathological Staging pT 3 N o m Stage: _I7 Notes: Nadey ( Mz, M.2, =legelice ) 4

--- Page 5 ---
Microscopic Description HistologicalPattern Cell Distribution + Structural Pattern +  Diffuse  Streaming Mosaic  Storiform  Necrosis Fibrosis  Lymphocytic Infiltration  Palisading  Vascular Invasion Cystic Degeneration Clusterized  Bleeding  Alveolar Formation  Myxoid Change  Indian File  Psammoma/Calcification a Cellular Differentiation Squamous + Adenomatous + - Sarcomatous + Lymphomatous + Squamoid Cell Glandular cell Round Cell Large Cell Spindle Cell Cell Stratification  Fibroblast Small Cell Keratin Secretion Osteoblast RS Cell/RS Like  Desmosome Intracyt. Vacuole  Lipoblast Inflam. Cell  Pear! Gland formation  Myoblast Plasma Cell Cellular Differentiation: Well Moderate Poor Nuclear Appearance Nuclear Atypia: 0 1 II III Aniso Nucleosis Hyperchromatism Nucleolar Prominent Multinucleated Giant Cell Mitotic Activity Nuclear Grade:  Marker Result Value Date ER  Negative   Positive PR Negative   Positive Her-2/neu  Negative  Positive  Negative  Positive B-Cell Marker T-Cell Marker  Negative  Positive Other:  Negative  Positive Other:  Negative  Positive Final Pathology Report w zhe colem Histological Diagnosis: DuCi D i cclen0c00iAumsG Grade:7 pinrlb C(ibconorliaTd) Comments: M, M2  Uegat'ue Pathologist 5

--- Page 6 ---
NSOLIdatED DIAgNOsTIC pAThOLOgy fORm* Microscopic Appearance: 1. Histological pattern: CELL DISTRIBUTION + STRUCTURAL PATTERN Diffuse Streaming XI  Mosaic XX  Storiform Necrosis Fibrosis Lymphocytic Infiltration  Palisading  Vascular Invasion X Cystic Degeneration Clusterized X Bleeding  Alveolar Formation x Myxoid Change Indian File X Psammoma/Calcification 2. Cellular features: Squamous + Adenomatous +  Sarcomatous + Lymphomatous + Squamoid Cell Glandular cell X Round Cell Large Cell  Spindle Cell Cell Stratification K Fibroblast Small Cell Osteoblast  RS CeIl/RS Like  Keratin Secretion  Desmosome Intracyt. Vacuole  Lipoblast  Inflam. Cell Gland formation  Myoblast  Plasma Cell Pear! D3 Otherwise Specified: 60% Dy. e o7r D;EO7 Ir6O% Neek[Y] 2.Cellular Differentiation: Moderately Poor Well 3. Nuclear Atypia: II HI Nuclear Appearance X  Aniso Nucleosis X Hyperchromatism Nucleolar Prominent X Multinucleated Giant Cell Mitotic Activity Nuclear Grade M, Mz :. omments: ATHOLOGIST STAFF FOR RESEARCH USE ONLY). *(INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR AN